Overview

VENICE Study Nevirapine Full Dose/Dose Escalation

Status:
Completed

Trial end date:
2009-02-01

Target enrollment:

Participant gender:

Summary

This study aims to compare the trough plasma concentrations of nevirapine after 7 days of treatment at the full dose from baseline with dose escalation in patients taking efavirenz who switch to nevirapine due to neuropsychiatric adverse reactions.

Phase:

Phase 4

Details

Lead Sponsor:

Clinical Trial Agency of HIV Study Group

Treatments:

Nevirapine